EUVIMEDEUVIMED entdecken
Crossref

Reprogramming Iron Metabolism via the RIG-I/c-Myc/FTH Axis Mitigates Renal Ischemia-Reperfusion Injury

Yulu Zhang iD, Jia Xing, Li Yao, Yu Zou, Hui Peng, Xiling Yi, Lifang Bai, Yang Yu, Hanzhe Liu, Xue Li, Xiaoyue Zhai

Antioxidants & Redox Signaling · 2025

DOI: 10.1177/15230864251369883 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants & Redox Signaling, 2025. Verfasst von Yulu Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, Basic Medical College, China Medical University, Shenyang, China. Hauptthemen laut MEDLINE: Reperfusion Injury, Iron, Proto-Oncogene Proteins c-myc, DEAD Box Protein 58. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Iron metabolism disorders are critical in the pathogenesis of acute kidney ischemia-reperfusion injury (IRI). However, the molecular mechanisms driving these disturbances remain poorly understood.

Results

In IRI mouse kidneys, pathological alterations, iron metabolism disruptions, and functional impairments were observed. Retinoic acid-inducible gene-I (RIG-I), transcription factor c-Myc, and ferritin heavy chain (FTH) exhibited elevated expression and colocalization in tubular epithelial cells, accompanied by decreased glutathione peroxidase 4 (GPX4) level and evidence of ferroptosis. Further in vitro studies revealed that RIG-I promoted c-Myc activation. The latter demonstrated its positive regulation of FTH transcription by chromatin immunoprecipitation assays and c-Myc siRNA experiments. Interestingly, FTH overexpression resulted in elevated levels of RIG-I, transferrin receptor, ferroportin, and nuclear receptor coactivator 4. Ultimately, the c-Myc inhibitor 10058-F4 reversed all adverse alterations and demonstrated a protective role in IRI mouse kidneys and mouse kidney tubule cells subjected to the ferroptosis inducer erastin, RIG-I agonist, or hypoxia/reoxygenation. This reversal was reflected in improved renal morphology and function, balanced iron metabolism, increased GPX4 level, decreased 4-hydroxynonenal level, reduced inflammatory cell infiltration, interleukin-1 beta release, and kidney injury molecule 1 expression. Innovation: This study proposes a novel mechanism in which c-Myc is activated by elevated RIG-I in IRI kidneys and positively regulates FTH transcription, therefore involving iron metabolism disorders.

Conclusions

The RIG-I, c-Myc, and FTH disrupt iron homeostasis, and the c-Myc inhibition stabilizes iron metabolism and mitigates oxidative stress, suggesting a potential therapeutic target in IRI. Antioxid. Redox Signal. 43, 622–636.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryIronProto-Oncogene Proteins c-mycDEAD Box Protein 58ApoferritinsAnimalsMiceFerroptosisMaleKidneyHumansDisease Models, AnimalMice, Inbred C57BL

Stichwörter der Autor:innen

C-Mycacute kidney injuryiron metabolismischemia-reperfusion injuryoxidative stress

Substanzen

IronProto-Oncogene Proteins c-mycDEAD Box Protein 58ApoferritinsDdx58 protein, mouseMyc protein, mouse

Autor:innen und Institutionen

  • Department of Histology and Embryology, Basic Medical College, China Medical University, Shenyang, China.
  • Department of Nephrology, The First Hospital of China Medical University, Shenyang, China.
  • Institute of Nephropathology, Basic Medical College, China Medical University, Shenyang, China.
  • Department of Nephrology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Department of Obstetrics and Gynaecology, Shenyang Women and Children's Hospital, Shenyang, China.
  • The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.

ORCID-Profile: Yulu Zhang

Zitieren

APA

Zhang, Y., Xing, J., Yao, L., Zou, Y., Peng, H., Yi, X., Bai, L., Yu, Y., Liu, H., Li, X., & Zhai, X. (2025). Reprogramming Iron Metabolism via the RIG-I/c-Myc/FTH Axis Mitigates Renal Ischemia-Reperfusion Injury. Antioxidants & Redox Signaling. https://doi.org/10.1177/15230864251369883

Vancouver

Zhang Y, Xing J, Yao L, Zou Y, Peng H, Yi X, et al. Reprogramming Iron Metabolism via the RIG-I/c-Myc/FTH Axis Mitigates Renal Ischemia-Reperfusion Injury. Antioxidants & Redox Signaling. 2025. doi:10.1177/15230864251369883

BibTeX
@article{Zhang2025,
  author = {Zhang, Yulu and Xing, Jia and Yao, Li and Zou, Yu and Peng, Hui and Yi, Xiling and Bai, Lifang and Yu, Yang and Liu, Hanzhe and Li, Xue and Zhai, Xiaoyue},
  title = {Reprogramming Iron Metabolism via the RIG-I/c-Myc/FTH Axis Mitigates Renal Ischemia-Reperfusion Injury},
  journal = {Antioxidants & Redox Signaling},
  year = {2025},
  doi = {10.1177/15230864251369883}
}
Kostenlos starten →